Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Canetti, D."'
Autor:
Fontana M; University College London, London, United Kingdom., Gilbertson J; University College London, London, United Kingdom., Verona G; University College London, London, United Kingdom., Riefolo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Slamova I; University College London, London, United Kingdom., Leone O; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rowczenio D; University College London, London, United Kingdom., Botcher N; University College London, London, United Kingdom., Ioannou A; University College London, London, United Kingdom., Patel RK; University College London, London, United Kingdom., Razvi Y; University College London, London, United Kingdom., Martinez-Naharro A; University College London, London, United Kingdom., Whelan CJ; University College London, London, United Kingdom., Venneri L; University College London, London, United Kingdom., Duhlin A; University College London, London, United Kingdom., Canetti D; University College London, London, United Kingdom., Ellmerich S; University College London, London, United Kingdom., Moon JC; University College London, London, United Kingdom., Kellman P; National Institutes of Health, Bethesda, MD., Al-Shawi R; University College London, London, United Kingdom j.gillmore@ucl.ac.uk., McCoy L; University College London, London, United Kingdom j.gillmore@ucl.ac.uk., Simons JP; University College London, London, United Kingdom j.gillmore@ucl.ac.uk., Hawkins PN; University College London, London, United Kingdom j.gillmore@ucl.ac.uk., Gillmore JD; University College London, London, United Kingdom j.gillmore@ucl.ac.uk.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2023 Jun 08; Vol. 388 (23), pp. 2199-2201.
Autor:
Slamova I; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Adib R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; London Institute of Medical Sciences, Imperial College London, London, UK., Ellmerich S; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Golos MR; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; School of Biological Sciences, University of Bristol, Bristol, UK., Gilbertson JA; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Botcher N; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Canetti D; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Taylor GW; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Rendell N; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Tennent GA; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Verona G; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Porcari R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Mangione PP; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Gillmore JD; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Pepys MB; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Bellotti V; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Hawkins PN; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Al-Shawi R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Simons JP; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK. p.simons@ucl.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Dec 07; Vol. 12 (1), pp. 7112. Date of Electronic Publication: 2021 Dec 07.
Autor:
Raimondi S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Mangione PP; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Verona G; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Canetti D; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Nocerino P; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Marchese L; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Piccarducci R; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.; Department of Pharmacy, University of Pisa, Pisa, Italy., Mondani V; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Faravelli G; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Taylor GW; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom., Gillmore JD; National Amyloidosis Centre, University College London and Royal Free Hospital, London, United Kingdom., Corazza A; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.; Department of Medicine (DAME), University of Udine, Udine, Italy.; Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy., Pepys MB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.; National Amyloidosis Centre, University College London and Royal Free Hospital, London, United Kingdom., Giorgetti S; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy s.giorgetti@unipv.it v.bellotti@ucl.ac.uk.; Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy., Bellotti V; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy s.giorgetti@unipv.it v.bellotti@ucl.ac.uk.; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, United Kingdom.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2020 Aug 14; Vol. 295 (33), pp. 11379-11387. Date of Electronic Publication: 2020 Jun 22.